Appraisal of antihypertensive drug therapy.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality; D002542:Intracranial Embolism and Thrombosis / Q000150:complications; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D010919:Placebos; D011446:Prospective Studies; D012110:Reserpine / Q000627:therapeutic use; D012164:Retinal Diseases / Q000150:complications; D014481:United States; D014493:United States Department of Veterans Affairs; D014652:Vascular Diseases / Q000150:complications
D000959:Antihypertensive Agents; D010919:Placebos; D006852:Hydrochlorothiazide; D006830:Hydralazine; D012110:Reserpine